Brazilian Network for HIV Drug Resistance Surveillance (HIV-BResNet)

2003192 citationsJournal Article

Authors

Rodrigo Brindeiro · Laboratory of Molecular Genetics

Ricardo Sobhie Diaz · Universidade Federal do Rio de Janeiro

Éster Cerdeira Sabino

Mariza Gonçalves Morgado · Instituto de Biologia do Exército

Ivone L. Pires · Universidade de São Paulo

Luís Fernando de Macedo Brígido · Instituto Adolfo Lutz

Maria C Dantas

Dráurio Barreira

Abstract

Brazil has a low prevalence of drug-resistant strains circulating among recently diagnosed individuals. However, there was an increase in these rates compared with similar studies performed with samples collected in Brazil from 1996 to 1998. Continued surveys are required to detect trends in these rates, but routine genotypic testing in the drug-naive population prior to antiretroviral initiation is not required in Brazil.

Topics & Keywords

HIV/AIDS drug development and treatment HIV/AIDS Research and Interventions HIV Research and Treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: AIDS

Volume 17, Issue 7, pp. 1063-1069

DOI: 10.1097/00002030-200305020-00016

Field-Weighted Citation Impact: 7.49